Best Uranium Stocks for Q2 2026

The Best Uranium Stocks for Q2 2026 tend to pair leverage to higher uranium prices with the balance sheets and assets to stay invested through the cycle. This group leans into a tight supply backdrop, rising reactor demand, and growing baseload needs from AI data centers and decarbonization goals, all of which may keep uranium prices supported into 2026 and beyond. Readers can expect a focus on producers, fuel-cycle specialists, and developers that could benefit if uranium prices remain elevated while still carrying notable project and policy risks.

Summary

What Are Uranium Stocks?

Uranium stocks are shares of companies that explore for, mine, process, or service the fuel that powers nuclear reactors. These businesses sit across the nuclear fuel chain: some search for and develop new uranium deposits, others run active mines, and a few handle conversion, enrichment, or related services. When traders look for the Best Uranium Stocks for Q2 2026, they are usually focusing on companies that stand to benefit if uranium demand stays firm and prices remain elevated.

Interest in uranium has picked up as more countries lean on nuclear power to cut carbon emissions while keeping the lights on. Reactor restarts, new nuclear plants, and early work on small modular reactors all increase demand for uranium fuel. At the same time, years of low prices led to reduced investment and mine closures, which limits supply. This mix of growing demand and tighter supply is what makes uranium stocks a distinct, often more volatile corner of the energy market that many investors watch closely.

Why Is Cameco (CCJ) Ranked #1 Among the Best Uranium Stocks for Q2 2026?

Why It's #1

Cameco is ranked #1 among the Best Uranium Stocks for Q2 2026 because it combines scale, cash generation, and direct leverage to uranium prices. The company is one of the largest pure-play uranium producers in the world, supplying fuel to nuclear reactors across many countries. With about $2.5 billion in annual revenue and a market value near $44 billion, it sits at the center of the global nuclear fuel chain rather than at the speculative fringe.

Financially, Cameco brings the mix many uranium investors look for: growth, cash, and balance-sheet strength. Revenue grew about 11% year over year, and free cash flow reached roughly $770 million, giving it room to reinvest and manage cycles. The stock has delivered a 1-year gain of around 45.8% and trades near $101, but that performance comes with a rich valuation, at roughly 94x trailing earnings and about 53x forward earnings, so expectations are high heading into Q2 2026.

Key Catalysts

• Demand tailwind from nuclear growth: A projected roughly 28% increase in global uranium demand by 2030 could support Cameco’s volumes and pricing power over the next several years.
• AI-driven power needs: Rising electricity demand from AI and cloud data centers, including nuclear-backed power deals by large tech firms, may translate into steadier long-term uranium contracts for Cameco.
• Near-term earnings event: The Q2 2026 earnings release on July 31 could update guidance, contract progress, and uranium price exposure, potentially shifting investor expectations.
• Visibility through themed funds: Being a major weight in nuclear-themed funds keeps Cameco in front of new capital whenever nuclear or uranium baskets attract inflows.

Strengths

• Scaled producer: Around $2.5 billion in annual revenue and a roughly $44 billion market cap position Cameco as a core, large-scale uranium supplier rather than a small speculative miner.
• Strong cash generation: Free cash flow of about $770 million gives Cameco room to fund projects, manage its mines, and navigate uranium price swings without relying heavily on new debt or equity.
• Consistent top-line growth: Revenue grew roughly 11% year over year, showing that Cameco is converting higher uranium prices and volumes into real sales growth.
• Proven recent stock momentum: The share price is up about 45.8% over the past year and 2.4% year to date, reflecting how investors have rewarded Cameco’s role in the uranium cycle.
• Institutional endorsement: Cameco’s role as a top holding in nuclear-focused baskets suggests large investors view it as a foundational way to gain uranium exposure.

Risks and Challenges

• Rich valuation: A trailing P/E around 94 and forward P/E above 53 mean the stock is priced for strong growth, leaving less room for error if uranium prices or earnings disappoint.
• Dependence on AI and data center spend: If large tech firms slow data center build-outs or choose non-nuclear power sources, the optimistic long-term demand story for Cameco’s uranium could soften.
• Regulatory and policy uncertainty: Delays or setbacks in nuclear-friendly power market rules may limit how much reactors run and, in turn, how much uranium utilities need from Cameco.
• Volatility via theme funds: Because Cameco is a key holding in nuclear-focused baskets, sharp moves in its stock can be amplified by fund flows, adding another layer of volatility for holders.
• Fund-structure headwinds for indirect holders: Investors accessing Cameco mainly through uranium or nuclear funds may see returns reduced by fund fees and index design, even if Cameco’s own performance is solid.

Why Is BWX Technologies (BWXT) Ranked #2 Among the Best Uranium Stocks for Q2 2026?

Why It's #2

BWX Technologies is ranked #2 among the Best Uranium Stocks for Q2 2026 because it blends high-end nuclear technology with growing fuel-cycle exposure and solid financial momentum. The company designs and manufactures nuclear reactors, fuel, and critical components, with a key role in U.S. Navy nuclear programs and advanced commercial nuclear projects. That mix gives it leverage to both defense and civilian nuclear demand rather than relying only on mined uranium prices.

Fundamentals help explain its high rank. Revenue has climbed to about $3.2 billion with year-over-year growth of 18.3%, while free cash flow sits near $295.3 million, giving BWXT room to fund new enrichment projects and acquisitions. At a market cap of roughly $17.7 billion and a current share price around $193, the stock trades at a rich trailing P/E of 51.6 and forward P/E of 37.2, but that valuation is supported by raised 2026 guidance and a visible contract backlog. The 0.5% dividend yield and 6.7% year-to-date return suggest investors are paying more for earnings visibility and strategic positioning than for income today.

Key Catalysts

• Fuel-cycle expansion: BWXT’s push into uranium enrichment and advanced nuclear fuels may open new revenue streams tied to both defense fuel needs and commercial reactor demand over the next several years.
• Centrifuge facility ramp: The January 2026 opening of the Centrifuge Manufacturing Development Facility in Oak Ridge lays the groundwork for BWXT’s enrichment ambitions and could support higher fuel-related sales if ramp-up goes to plan.
• Planned enrichment plant: BWXT’s notice to the U.S. Nuclear Regulatory Commission about a new uranium enrichment facility positions the company as a potential key supplier for U.S. energy and defense security once licensed and built.
• Backlog conversion: Higher 2026 revenue guidance above $3.75 billion, backed by a growing multi-year contract backlog, could support continued mid-teens growth if projects stay on schedule.
• Acquisition synergies: Integrating Precision Components Group may allow BWXT to capture more value across the nuclear component supply chain, potentially lifting margins over time if execution is smooth.

Strengths

• Defense anchor: A sole-source position on critical U.S. Navy nuclear programs gives BWXT long-term contracts, high switching costs, and a stable revenue base that many uranium peers lack.
• Double-digit growth: Annual revenue of about $3.2 billion combined with 18.3% year-over-year growth shows BWXT is already scaling quickly from a sizable base.
• Cash to reinvest: Free cash flow of roughly $295 million provides funding for enrichment projects, acquisitions, and potential future shareholder returns without heavy reliance on new debt or equity.
• Upward guidance: Management has raised 2026 revenue guidance to more than $3.75 billion, signaling confidence in converting its government and commercial backlog into actual sales.
• Broader manufacturing footprint: The April 2026 acquisition of Precision Components Group expands BWXT’s U.S. nuclear manufacturing capabilities and helps deepen its moat in high-spec components.

Risks and Challenges

• Budget reliance: Heavy exposure to U.S. government defense and nuclear spending means changes in budget priorities or contract timing could slow growth or squeeze the backlog.
• Enrichment build-out risk: Delays or cost overruns in the centrifuge program or planned enrichment plant could hurt margins and delay the expected 2026–2027 revenue uplift from fuel-cycle expansion.
• Regulation uncertainty: NRC licensing requirements and shifting nuclear fuel policies could alter the economics or timelines of BWXT’s enrichment projects, affecting how quickly new earnings show up.
• Rich valuation: With a trailing P/E of 51.6 and forward P/E of 37.2, the stock leaves less room for mistakes if backlog conversion, enrichment ramp-up, or commercial nuclear demand do not meet expectations.
• Capital intensity: Larger capital projects and acquisitions increase BWXT’s need for precise execution and may pressure margins if pricing and contract mix do not fully cover higher investment costs.

Why Is NexGen Energy (NXE) Ranked #3 Among the Best Uranium Stocks for Q2 2026?

Why It's #3

NexGen Energy is ranked #3 among the Best Uranium Stocks for Q2 2026 because it offers high upside to uranium prices through a world-class project, but still carries full pre-production risk. The company is a pure-play uranium developer focused on the Rook I project in Canada’s Athabasca Basin, often described as one of the best undeveloped uranium assets globally. With a mid-cap market value of about $6.5 billion and a share price near $9.85, it sits in a size range where project news can move the stock meaningfully.

NexGen remains pre-revenue, reporting $0 in annual sales and free cash flow of about -$166.9 million (converted from CAD), which reflects heavy spending to advance Rook I rather than generate income. Earnings per share are negative at -$0.49, and the forward P/E of -56.4 shows that valuation is based on expected future production, not current profits. The stock has pulled back year-to-date (-3.9%) from a 52-week high of $13.96, but its high “torque” to uranium prices and recent construction license for Rook I keep it positioned as a high-beta way to express a bullish uranium view for 2026 and beyond.

Key Catalysts

• Construction license milestone: On March 5, 2026, the Canadian Nuclear Safety Commission granted NexGen the license for site preparation and construction at Rook I, moving the project from pure exploration into early development and de-risking a key regulatory step.
• Project advancement toward production: Each phase of advancing Rook I - from early works to full mine construction - could reset investor expectations around timing and scale of future uranium output.
• Potential demand tailwind: Commentary for 2026 points to an expected roughly 28% rise in global uranium demand by 2030, and NexGen aims to bring Rook I online into that tighter market, which may support long-term pricing and offtake interest.
• Room to react to news: With a year-to-date return of -3.9% and the share price below its 52-week high of $13.96, positive developments around permitting, construction, or uranium prices could have visible impact on the stock if sentiment improves.

Strengths

• World-class resource base: The Rook I project in Canada’s Athabasca region is described as one of the best undeveloped, high-grade uranium assets globally, giving NexGen significant long-term production potential if fully built out.
• Pure uranium exposure: As a focused uranium developer with no side businesses, NexGen provides direct leverage to uranium price moves, which may appeal to investors with a strong view on the uranium cycle.
• Mid-cap scale: A market cap of about $6.5 billion places NexGen in the mid-cap range, large enough to attract institutional interest while still small enough that project milestones can materially affect the share price.
• Recognized sector name: NexGen is a well-known developer that often attracts capital flows during bullish uranium periods, which can support trading liquidity and valuation when sector sentiment is positive.

Risks and Challenges

• No current operating revenue: NexGen reports $0 in annual revenue, so the investment case depends entirely on future production rather than existing cash-generating operations.
• Ongoing cash burn: Free cash flow of roughly -$166.9 million (converted from CAD) highlights that the company is spending heavily on development and will likely need continued access to outside funding until Rook I is producing.
• Valuation tied to future hopes: A forward P/E of -56.4 and EPS of -$0.49 indicate that the stock is priced on expectations of future uranium production, which can be sensitive to setbacks in project timing or uranium prices.
• High sensitivity to uranium prices: Project economics and valuation rely on uranium prices staying supportive; a downturn in uranium sentiment could hit NexGen harder than diversified producers because of its high “torque” to the cycle.
• Financing dependence: As a speculative developer without cash flow from operations, NexGen remains exposed to capital market conditions; weaker appetite for uranium developers could make funding Rook I more challenging or more dilutive.

Why Is Paladin Energy (PALAF) Ranked #4 Among the Best Uranium Stocks for Q2 2026?

Why It's #4

Paladin Energy is ranked #4 among the Best Uranium Stocks for Q2 2026 because it combines a fast-ramping production profile with more moderate valuation expectations than many peers. The company operates as a mid-cap uranium producer and developer, giving it direct exposure to uranium prices as mines restart and new capacity comes online. Annual revenue has jumped to $177.7 million, with year-over-year growth of about 3,680%, reflecting the transition from near-zero sales toward scaled production.

This growth story is still early and not yet fully reflected in profits. Paladin’s earnings per share sit at -$0.11 and free cash flow is negative at about -$52.6 million, showing that the ramp-up phase is cash-hungry. However, the stock trades on a forward P/E of 14.9, which many investors may view as more reasonable for a growth producer than richer multiples elsewhere in the space. The share price at $6.99 sits well below its 52-week high of $10.50, and only slightly above its $3.81 low, suggesting both upside potential and meaningful volatility as execution risks play out.

Key Catalysts

• Production ramp momentum: The move to $177.7 million in revenue, up about 3,680% year over year, suggests that continued production ramping could further lift sales if uranium prices hold up.
• Potential earnings turnaround: With EPS currently at -$0.11, improving mine output and cost control could push Paladin toward breakeven and eventually positive earnings, which often acts as a re-rating catalyst.
• Room for sentiment-driven re-pricing: If uranium prices stay firm and operations deliver as planned, the 14.9x forward earnings multiple may leave room for a sentiment uplift compared with richer-valued peers.

Strengths

• Explosive revenue ramp: Annual revenue has surged to $177.7 million, up about 3,680% year over year as production scales from a low base.
• More moderate valuation: A forward P/E of 14.9 prices Paladin more conservatively than many high-growth uranium names, which may appeal to investors seeking growth at a less demanding multiple.
• Mid-cap scale: A market value of roughly $3.1 billion places Paladin in the mid-cap range, large enough to fund development but still small enough that further production growth could materially move the needle.
• Visible trading range: The current share price of $6.99 sits between a 52-week low of $3.81 and a high of $10.50, showing the stock has already proven it can trade meaningfully higher in more favorable sentiment.

Risks and Challenges

• Cash burn during ramp-up: Free cash flow of about -$52.6 million shows the business is still consuming cash, which may require ongoing funding until operations fully stabilize.
• Unprofitable at present: EPS of -$0.11 underlines that Paladin has not yet reached consistent profitability, so any setbacks in production or prices could weigh heavily on results.
• Wide trading swings: A 52-week range from $3.81 to $10.50 highlights significant volatility, meaning sentiment shifts around uranium prices or project news can move the stock sharply in either direction.
• Uranium price dependence: As a pure-play uranium producer and developer, Paladin’s cash flow and valuation remain highly sensitive to uranium price moves, which can be cyclical and policy-driven.

Why Is Uranium Energy (UEC) Ranked #5 Among the Best Uranium Stocks for Q2 2026?

Why It's #5

Uranium Energy is a growth-focused uranium producer that gives investors high-octane exposure to U.S. and Canadian uranium projects. The company is described as the largest uranium producer in the U.S., with in-situ recovery (ISR) operations that can ramp production faster than traditional mines. It runs a vertically integrated model and holds uranium inventory on its balance sheet, aiming to benefit directly if uranium prices rise.

UEC earned the #5 spot because its upside potential comes with clear financial and stock-price risks. Market cap sits at about $5.4B, yet annual revenue is only $66.8M, highlighting how much of the valuation is based on future growth rather than current earnings. The company is still losing money, with EPS at -$0.22 and free cash flow around -$70.2M, and the forward P/E is a deeply negative -183.8, signaling a rich valuation for a loss-making business. The stock is also down about 15.9% year-to-date and trades well below its 52-week high of $20.34 versus a recent price of $11.03, underlining both volatility and potential sensitivity to sentiment shifts.

Key Catalysts

• Price-upside catalyst: Keeping production and roughly $111.9M of uranium inventory unhedged could amplify cash flow growth if uranium prices stay firm or move higher into 2026.
• Project development runway: Advancing selected projects from a 62-asset pipeline toward production over the next few years may lift output, grow revenue, and improve operating efficiency.
• Policy tailwind potential: A supportive U.S. policy stance toward domestic uranium supply may open doors to government-related demand, funding programs, or favorable permitting outcomes for UEC projects.
• Rebound potential: With shares at about $11.03 versus a 52-week high of $20.34, any improvement in uranium sentiment, project milestones, or financial results could support a recovery toward prior trading ranges, though this is not guaranteed.

Strengths

• Scale and structure: As the largest U.S. uranium producer with vertically integrated in-situ recovery (ISR) operations, Uranium Energy may be able to ramp production faster and at lower operating costs than many conventional miners.
• Inventory leverage: A no-hedging policy combined with roughly $111.9M of uranium inventory on the balance sheet means UEC is positioned to benefit more directly if uranium spot and contract prices rise.
• Large project pipeline: A portfolio of 62 projects across the U.S. and Canada provides many paths for future production growth and exploration upside, though it adds complexity to execution.
• Balance sheet flexibility: Around $543M in current assets gives UEC financial flexibility to fund development, carry inventory, and ride out weaker periods in the uranium market.
• Integrated operations: Vertical integration through mining and processing can keep more of the uranium value chain in-house, which may support margins if volumes scale over time.

Risks and Challenges

• Valuation and earnings risk: A market cap of $5.4B against $66.8M in revenue, EPS of -$0.22, free cash flow of -$70.2M, and a forward P/E of -183.8 suggests the stock prices in significant future success while the business is still losing money.
• High-volatility profile: A year-to-date return of -15.9% and a history of sharp moves underline how sensitive UEC’s share price can be to swings in uranium sentiment and technical trading levels.
• Commodity downside exposure: The no-hedging approach means cash flows and project economics are fully exposed if uranium prices stall or fall, which could strain the balance sheet and delay growth plans.
• Execution complexity: Managing 62 projects in two countries raises the risk of spreading capital and management attention too thin, which could lead to delays, cost overruns, or the need for extra funding.
• Short-interest overhang: Short interest near 9% suggests a meaningful group of traders is betting against the stock, which can weigh on sentiment and add to downside pressure during weak periods.

Why Is Denison Mines (DNN) Ranked #6 Among the Best Uranium Stocks for Q2 2026?

Why It's #6

Denison Mines is a smaller, pure-play uranium developer that offers high leverage to uranium prices but comes with early-stage financials and higher risk. The company’s current revenue is tiny at about $3.5 million (converted from CAD), and it is still burning cash with roughly -$85 million in free cash flow, so the story is more about future potential than current earnings. With a market value near $2.8 billion and a negative forward P/E around -75.5, investors are mainly paying for what Denison might become if uranium prices stay firm or move higher.

Denison earned the #6 spot because it combines speculative upside with weaker fundamentals compared with larger producers and more advanced developers. Revenue is growing quickly off a low base, up about 22.2% year over year, and the stock is up roughly 1.0% so far in 2026 after a strong prior 12 months. Trading around $3.06, between a 52-week low of $1.67 and a high of $4.43, the shares may appeal to investors who want direct exposure to uranium sentiment and are comfortable with volatility and a long timeline.

Key Catalysts

• Nuclear policy tailwind: Structural limits on uranium supply and ongoing policy support for nuclear power could lift uranium prices, which would likely have an outsized impact on Denison’s future project economics.
• Growing demand outlook: Forecasts for roughly 28% growth in global uranium demand by 2030, driven by reactor builds and power needs, could improve the long-term value of Denison’s undeveloped resources.
• Sector inflows signal: A custom uranium equity index that includes Denison gained about 30% in January 2026, highlighting renewed investor interest in uranium names that could support capital raising and valuations.
• Momentum-driven interest: Ongoing bullish performance in uranium equities since early 2025, with Denison part of that basket, may keep momentum traders and uranium-focused funds engaged in the name.

Strengths

• Pure uranium exposure: Inclusion in a custom uranium equity index alongside Cameco, NexGen, and a uranium miners ETF signals that Denison is viewed as a meaningful pure-play way to gain exposure to the uranium cycle.
• Meaningful but mid-sized scale: A roughly $2.8 billion market cap gives Denison more heft than many micro-cap explorers while still leaving room for investor expectations of future growth to matter.
• Early revenue with fast growth: Annual revenue of about $3.5 million (converted from CAD) is small but has grown roughly 22.2% year over year, showing some progress in moving projects forward.
• Active trading range: The stock’s move between a $1.67 low and a $4.43 high over the past year, with a current price near $3.06, points to solid liquidity and meaningful trading interest around uranium news.

Risks and Challenges

• Cash burn and early-stage profile: Negative free cash flow of about -$85 million against only $3.5 million in revenue means Denison relies on external funding and carries typical early-stage project risk.
• Valuation tied to future hopes: A negative forward P/E near -75.5 and EPS of -$0.23 show that investors are paying for anticipated future uranium upside rather than current profits, which could backfire if projects are delayed or costs rise.
• Price-sensitive business model: Denison’s fortunes are tightly linked to uranium prices, so a flat or falling price environment could quickly pressure the share price and delay development plans.
• Demand forecast uncertainty: The thesis leans on a projected ~28% rise in uranium demand by 2030; slower reactor builds or policy shifts away from nuclear would weaken this key support.
• Crowded sentiment risk: After a roughly 30% January 2026 jump and several bullish months since early 2025 in the uranium index that includes Denison, a setback in macro conditions or uranium fundamentals could trigger a sharp pullback as sentiment cools.

How Do These Uranium Stocks Compare?

What Key Risks Could Hit the Best Uranium Stocks for Q2 2026?

The Best Uranium Stocks for Q2 2026 face several sector-wide risks that could quickly change sentiment and valuation. Even with a positive long-term story, uranium remains a cyclical commodity whose price can swing sharply when macro conditions, policy, or investor appetite shift.

A first major risk is uranium price volatility. If global growth slows, power demand could soften and utilities may delay contracting, which can pressure spot prices and hit miners’ earnings. On the flip side, rapid price spikes can also backfire: very high prices may encourage new supply, bring marginal projects online, and tempt governments to release strategic inventories, all of which can cap future upside. Because many names in the Best Uranium Stocks for Q2 2026 are highly tied to the commodity price, even modest moves in uranium can cause outsized share-price swings.

Policy and regulatory uncertainty are another big overhang. Nuclear power depends on government approvals, waste rules, and safety standards, which can change after an accident, a change in leadership, or a public backlash. Stricter rules can delay projects, raise costs, or force plant closures, which would weigh on fuel demand. Geopolitics layer on extra risk: sanctions, trade restrictions, or export bans from key producing regions can disrupt supply chains and shift contract flows in unpredictable ways. Finally, execution and technology risk around new reactors and small modular reactors could slow the demand ramp; if projects are delayed, over budget, or canceled, uranium demand growth may fall short of current expectations, leaving highly levered developers exposed if capital markets cool at the same time.

Key Takeaways

• Best Uranium Stocks for Q2 2026 center on Cameco as the liquid blue-chip, benefiting most from sustained high uranium prices and long-term supply contracts.
• BWX Technologies offers more stable exposure to the nuclear theme through government-backed fuel and services, with less direct sensitivity to spot uranium price swings.
• NexGen Energy and Denison Mines provide higher-risk development upside tied to advancing flagship Canadian projects toward production and securing long-term offtake deals.
• Paladin Energy and Uranium Energy give leveraged exposure to a uranium upcycle through restartable or scalable mines, but their earnings depend heavily on execution and contract timing.
• Across all six names, the bullish case rests on a structural uranium supply deficit, ongoing reactor builds, and nuclear’s growing role in meeting AI and decarbonization power demand.
• Key risks for these uranium stocks include commodity price volatility, project delays, permitting or political setbacks, and potential changes in nuclear energy policy by major countries.

Frequently Asked Questions

Is Cameco (CCJ) a large uranium stock and how has it performed in 2026 so far?

Cameco (CCJ) is one of the largest uranium-focused names with a market cap of about $44.0 billion and a share price near $100.96. Its year-to-date performance as of June 2026 is modest, up around 2.4%.

How exposed is BWX Technologies (BWXT) to government nuclear spending?

BWX Technologies depends heavily on U.S. government defense and nuclear budgets for its multi-year contract backlog. Any shift in budget priorities or slower procurement cycles could affect its $17.7 billion valuation and growth path.

Why is NexGen Energy (NXE) considered higher risk compared with established uranium producers?

NexGen Energy, with a market cap near $6.5 billion and a share price around $9.85, is still pre-revenue and relies on future development of its uranium deposits. Its valuation leans on expectations for strong uranium prices and successful build-out of projects like Rook I, which may face permitting, construction, and timeline risks.

What makes Uranium Energy Corp (UEC) more volatile than some other uranium stocks?

Uranium Energy Corp, trading around $11.03 with a market cap of $5.4 billion, has a high-beta profile and a no-hedging strategy, so its results move closely with uranium price swings. Rising short interest of about 9% can also add to share price volatility during market pullbacks.

What are the main sector-wide risks for uranium stocks like Denison Mines (DNN) and Paladin Energy (PALAF)?

Many uranium names, including Denison Mines at about $3.06 and Paladin Energy near $6.99, depend on forecasts that global uranium demand could rise roughly 28% by 2030. Changes in nuclear policy, slower nuclear build-outs, weaker AI-driven power demand, or relaxed restrictions on uranium production could all put pressure on prices and valuations across the sector.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.